Svetlana N. Nasonova

Svetlana N. Nasonova

Auto-generated profile, based on publicly available information

Svetlana N. Nasonova

Chazov National Medical Research Center of Cardiology

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
STS N Tereshchenko
S N Tereshchenko
IZI V Zhirov
I V Zhirov
OMOlga Moiseeva
Olga Moiseeva
TAT V Adasheva
T V Adasheva
ASA. Safiullina
A. Safiullina
VSV B Sergienko
V B Sergienko
This paper summarizes the data from updated international protocols and guidelines for diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). The invasive and non-invasive diagnosis techniques and their combinations are briefly reviewed; the evidentiary foundations for each diagnostic option and tool are analyzed. The paper describes a customized algorithm for sequential diagnosis and differential diagnosis of patients with suspected ATTR-CM with allowance for the combination of clinical signs and diagnostic findings. Along with the awareness of primary care providers about the red flags of the disease and visualization criteria, as well as providing information to the patients about the possibility of performing therapy of ATTR amyloidosis and the risks of delayed diagnosis, the proposed algorithm enables timely patient routing and prescribing specific treatment.

15 November 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AKAlexandra A. Korotaeva
Alexandra A. Korotaeva
ESElena V. Samoilova
Elena V. Samoilova
DMDzambolat R. Mindzaev
Dzambolat R. Mindzaev
SNSvetlana N. Nasonova
Svetlana N. Nasonova
IZIgor V. Zhirov
Igor V. Zhirov
STSergei N. Tereschenko
Sergei N. Tereschenko
Systemic inflammation is characterized by the induction of pro-inflammatory cytokines, the increased level of which in the blood of patients with chronic heart failure (CHF) correlates with unfavorable clinical outcomes. However, it is unclear whether pro-inflammatory cytokines are the cause or the consequence of the disease progression. CHF with preserved ejection fraction and CHF with reduced ejection fraction demonstrate different inflammatory features, which suggests different degrees of pro-inflammatory pathway activation. The review deals with participation of pro-inflammatory cytokines in pathophysiological processes of CHF development, emphasizing the role of interleukin-6 activation and the effects of accompanying diseases on the course of systemic inflammation. The search for new approaches to prevention and therapy of CHF remains actual. The review presents the results of clinical trials of targeted anti-cytokine therapy which have revealed difficulties in controlling inflammation under the conditions of CHF. Identification of specific pro-inflammatory pathways in CHF pathogenesis will allow one to control inflammatory cascades, thus providing a prospective therapeutic strategy.

15 April 2019 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
SNS N Nasonova
S N Nasonova
IZI V Zhirov
I V Zhirov
MLM V Ledyakhova
M V Ledyakhova
TST V Sharf
T V Sharf
EBE G Bosykh
E G Bosykh
STS N Tereshchenko
S N Tereshchenko
Early diagnosis of acute kidney injury (AKI) is an urgent problem of providing medical care to patients with acute decompensation of chronic heart failure (ADHF). Aim. To study the possibilities of previously diagnosing acute renal damage in patients with acute decompensation of chronic heart failure with reduced systolic function using biomarkers of acute renal injury. Materials and methods. The study included 60 patients (62.0±11.1 years) with HADS (BNP >500 pg/ml) and a reduced left ventricular ejection fraction (LV 27.05% [23.25; 32.75], c FC III–IV NYHA). The level of creatinine, urea, uric acid, albumin in serum was determined in all patients, as well as a number of biomarkers: lipocalin associated with neutrophil gelatinase (NGAL) and cystatin C (CysC) in serum; kidney damage molecule-1 (KIM-1) and angiotensinogen (AGT) in the urine. Results and discussion. AKI is determined based on changes in serum creatinine concentration or diuresis value. The results obtained indicate a high specificity and sensitivity of the use of biomarkers for the diagnosis of AKI in patients with ADHF. NGAL AUC – 0.833 (p<0.001), Se – 82.8%, Sp – 4.2%. CysC AUC – 0.823 (p<0.001), Se – 79.3%, Sp – 74.2%. KIM-1 AUC – 0.782 (p<0.001), Se – 75.9%, Sp – 74.2%. AGT AUC – 0.829 (p<0.001), Se – 82.8%, Sp – 77.4%. In a multifactorial regression analysis, it was found that with NGAL greater than 157.35 ng/ml, the risk of AKI increases 13.1 times (95% CI 1.365–126.431), with an increase in KIM-1, the risk of the development of AKI increases 20.6 times (95% CI 1.802–235.524), and with an increase in AGT more than 14.31 leng/ml, the risk of AKI increases 32.8 times (95% CI 2.752–390.110). Conclusion. Acute kidney injury develops in 48.3% of patients hospitalized with acute decompensation of chronic heart failure. Patients with acute decompensation of chronic heart failure and AKI have significantly higher serum NGAL and CysC, KIM-1 and AGT values in the urine compared with patients without impairing renal function. These biomarkers can serve both for the early diagnosis of acute kidney damage and the prediction of AKI in patients with acute decompensation of chronic heart failure. Keywords: acute renal injury, acute decompensation of heart failure, cardiorenal syndrome type I, biomarkers of acute renal injury

31 August 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
SNS. N. Nasonova
S. N. Nasonova
ALA. E. Lapteva
A. E. Lapteva
IZI. V. Zhirov
I. V. Zhirov
STS. N. Tereshchenko
S. N. Tereshchenko
SBSergey Boytsov
Sergey Boytsov
Prevalence of chronic heart failure (CHF) is continuously growing and is associated with increased incidence of hospitalizations, morbidity and mortality. Furthermore, the increase in the number of rehospitalizations results in greater expenses and worsening of quality of life. In order to decrease the number of unscheduled hospitalizations and the death rate, the outpatient care should be improved, which can be achieved by using telemedical technologies. The aim of this review was collection and analysis of currently available information about the use of telemonitoring for patients with CHF. A systematic search and analysis of reports published from 2010 through 2020 in Web of Science, Scopus, and PubMed/MEDLINE databases was performed.

24 October 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IZIgor V. Zhirov
Igor V. Zhirov
SNSvetlana N. Nasonova
Svetlana N. Nasonova
STSergey N. Tereshchenko
Sergey N. Tereshchenko
ТНТерещенко Сергей Николаевич
Терещенко Сергей Николаевич
Are presented the key aspects of the management of patients with acute decompensation of heart failure leading to improved clinical outcomes. Are described the existing problems and possible solutions.

27 May 2024 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
STS. N. Tereshchenko
S. N. Tereshchenko
IZI. V. Zhirov
I. V. Zhirov
TUT. M. Uskach
T. M. Uskach
MSM. A. Saidova
M. A. Saidova
SGS. P. Golicyn
S. P. Golicyn
OSO. V. Stukalova
O. V. Stukalova
The purpose of this guide is to assist cardiologists in the management of patients with chronic heart failure (CHF) in accordance with the available modern evidence base. This manual contains data on the diagnosis, treatment, and rehabilitation of patients with chronic heart failure and data on acute decompensation of heart failure.